Two additional genes, CCND1 and RB1, identified in the bladder cancer signaling network are known biomarkers [64], and the third gene identified in the bladder cancer signaling network (CDK4) is a known inhibitor of bladder cancer [65, 66]. The gene discussed is RB1; the disease is urinary bladder cancer.